Submitted by Anonymous (not verified) on 29 September 2026 - 10:00
Human medicines European public assessment report (EPAR): Xbryk, denosumab, Date of authorisation: 12/02/2025, Revision: 3, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Xbryk, denosumab, Date of authorisation: 12/02/2025, Revision: 3, Status: Authorised